"The Cholesterol Conspiracy" Revised 2nd Edition

How Pharmaceutical Companies Continue to Hide the Truth About Cholesterol.

Includes the Newest Research Findings Showing the Effectiveness of Nutritional Supplements for the Prevention of Heart Disease and Stroke.

This audiobook is read by the author, Ladd R. McNamara, M.D.

Copies of the Cholestrol Conspiracy are available!

Audio Book and Paper Back versions are available at http://www.laddmcnamara.com/bookstore along with other books written by Dr. McNamara.

Ladd McNamara, M.D. (Photo)

Episode 13: LDL Cholesterol and Diabetes

In this episode Dr. McNamara discusses The Real Importance of LDL Cholesterol and The Role of Diabetes and High Blood Sugar in the Development of Coronary Artery Disease

  • Chapter 31: The Importance of LDL Cholesterol
  • Chapter 32: The Role of Diabetes and High Blood Sugar in the Development of Coronary Artery Disease

Chapter Excerpts

Evidence supports the theory that when a person’s total cholesterol drops below 160, the immune system is weakened. Statin drugs, i.e., cholesterol-lowering drugs, are known to suppress the immune system.

Obesity leads to diabetes through oxidation of insulin receptors, and along with the oxidation of lipids (including cholesterol) and inflammation of the arterial wall leads to heart disease, stroke, and eventually death.

Chapter References

  • 74: Rauchhaus M, Clark A, Doehner W, Davos C, et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol. 2003 Dec 3; 42(11):1933-1940.
  • 75: Fuller C, Jialal I, et al. rrr-alpha-tocopherol acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus. Am J Clin Nutri. 1996 63:753-759.
  • 76: Somogyi A, et al. Hypothetical connection between diabetes mellitus and free radical reactions in arteriosclerosis. Orvosi Hetilap [Hungarian] 1994 135:(33):1815-1818.
  • 77: Jialal I. Effect of combined supplementation with alpha-tocopherol ascorbate and beta-carotene on low-density lipoprotein oxidation. Circulation. 1993 88:2780-2786.
  • 78: Munch G, Mayer S, Michaelis J, et al. Influence of advanced glycation end-products and AGE-ingivitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Acta. 1997 1360(1):17-29.
  • 79: Hipkiss A, Michaelis J, Syrris P. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett. 1995 371(1):81-85.
  • 80: Brownson C, Hipkiss A. Carnosine reacts with a glycated protein. Free Radic Biol Med. 2000 28(10):1564-1570.
  • 81: Yamano T, et al. Effect of L-carnosine on the hyperglycemia caused by intracranial injection of 2-deoxy-D-glucose in rats. Neurosci Lett 2001 Nov 2;313(1-2):78-82.
  • 82: Heitzer T, et al. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001 Jul 1;31(1):53-61.
  • 83: El Midaoui A, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension 2002 Feb;39(2):303-307.
  • 84: Takaoka M, et al. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur J Pharmacol 2001 Jul;20;424(2):121-129.

Post a Comment

Your email is never shared. Required fields are marked *

*
*